Logo image of AKO.B

EMBOTELLADORA ANDINA-ADR B (AKO.B) Stock Fundamental Analysis

USA - NYSE:AKO.B - US29081P3038 - ADR

22.58 USD
-0.44 (-1.91%)
Last: 10/10/2025, 9:09:40 PM
Fundamental Rating

4

Overall AKO.B gets a fundamental rating of 4 out of 10. We evaluated AKO.B against 33 industry peers in the Beverages industry. There are concerns on the financial health of AKO.B while its profitability can be described as average. AKO.B is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

AKO.B had positive earnings in each of the past 5 years.
Each year in the past 5 years AKO.B had a positive operating cash flow.
AKO.B Yearly Net Income VS EBIT VS OCF VS FCFAKO.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

1.2 Ratios

AKO.B has a better Return On Assets (8.29%) than 75.76% of its industry peers.
Looking at the Return On Equity, with a value of 24.09%, AKO.B belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
With a decent Return On Invested Capital value of 11.01%, AKO.B is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AKO.B is in line with the industry average of 10.78%.
The 3 year average ROIC (10.65%) for AKO.B is below the current ROIC(11.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.29%
ROE 24.09%
ROIC 11.01%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)19.28%
ROE(5y)17.45%
ROIC(3y)10.65%
ROIC(5y)9.4%
AKO.B Yearly ROA, ROE, ROICAKO.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AKO.B has a Profit Margin (7.66%) which is in line with its industry peers.
AKO.B's Profit Margin has declined in the last couple of years.
The Operating Margin of AKO.B (12.48%) is comparable to the rest of the industry.
AKO.B's Operating Margin has declined in the last couple of years.
AKO.B's Gross Margin of 39.38% is on the low side compared to the rest of the industry. AKO.B is outperformed by 66.67% of its industry peers.
In the last couple of years the Gross Margin of AKO.B has remained more or less at the same level.
Industry RankSector Rank
OM 12.48%
PM (TTM) 7.66%
GM 39.38%
OM growth 3Y-0.37%
OM growth 5Y-2.84%
PM growth 3Y1.12%
PM growth 5Y-5.87%
GM growth 3Y1.48%
GM growth 5Y-0.7%
AKO.B Yearly Profit, Operating, Gross MarginsAKO.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

AKO.B has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AKO.B remains at a similar level compared to 5 years ago.
AKO.B has a better debt/assets ratio than last year.
AKO.B Yearly Shares OutstandingAKO.B Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
AKO.B Yearly Total Debt VS Total AssetsAKO.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

The Debt to FCF ratio of AKO.B is 10.38, which is on the high side as it means it would take AKO.B, 10.38 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.38, AKO.B perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
A Debt/Equity ratio of 0.95 indicates that AKO.B is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.95, AKO.B is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 10.38
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
AKO.B Yearly LT Debt VS Equity VS FCFAKO.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.3 Liquidity

A Current Ratio of 1.32 indicates that AKO.B should not have too much problems paying its short term obligations.
The Current ratio of AKO.B (1.32) is comparable to the rest of the industry.
AKO.B has a Quick Ratio of 1.32. This is a bad value and indicates that AKO.B is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AKO.B (0.82) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.82
AKO.B Yearly Current Assets VS Current LiabilitesAKO.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

More info and screens

6

3. Growth

3.1 Past

AKO.B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.41%, which is quite good.
Measured over the past 5 years, AKO.B shows a small growth in Earnings Per Share. The EPS has been growing by 5.30% on average per year.
The Revenue has grown by 23.14% in the past year. This is a very strong growth!
AKO.B shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.63% yearly.
EPS 1Y (TTM)16.41%
EPS 3Y16.59%
EPS 5Y5.3%
EPS Q2Q%51.15%
Revenue 1Y (TTM)23.14%
Revenue growth 3Y13.3%
Revenue growth 5Y12.63%
Sales Q2Q%9.81%

3.2 Future

Based on estimates for the next years, AKO.B will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.29% on average per year.
Based on estimates for the next years, AKO.B will show a quite strong growth in Revenue. The Revenue will grow by 8.01% on average per year.
EPS Next Y13.57%
EPS Next 2Y9.71%
EPS Next 3Y9.29%
EPS Next 5YN/A
Revenue Next Year12.11%
Revenue Next 2Y8.04%
Revenue Next 3Y8.01%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKO.B Yearly Revenue VS EstimatesAKO.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1T 2T 3T
AKO.B Yearly EPS VS EstimatesAKO.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100 200 300

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
AKO.B Price Earnings VS Forward Price EarningsAKO.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AKO.B Per share dataAKO.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.71%
EPS Next 3Y9.29%

More info and screens

0

5. Dividend

5.1 Amount

AKO.B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMBOTELLADORA ANDINA-ADR B

NYSE:AKO.B (10/10/2025, 9:09:40 PM)

22.58

-0.44 (-1.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27
Inst Owners60.19%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.37B
Analysts75.56
Price Target26.69 (18.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)12.91%
DP79.22%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-24 2025-01-24 (0.957762)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.18%
Min EPS beat(2)0.1%
Max EPS beat(2)4.27%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)11.61%
EPS beat(8)5
Avg EPS beat(8)11%
EPS beat(12)6
Avg EPS beat(12)0.41%
EPS beat(16)9
Avg EPS beat(16)3.63%
Revenue beat(2)0
Avg Revenue beat(2)-2.04%
Min Revenue beat(2)-2.81%
Max Revenue beat(2)-1.27%
Revenue beat(4)1
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-2.81%
Max Revenue beat(4)6.98%
Revenue beat(8)4
Avg Revenue beat(8)-1.63%
Revenue beat(12)5
Avg Revenue beat(12)-1.7%
Revenue beat(16)9
Avg Revenue beat(16)9.57%
PT rev (1m)0.66%
PT rev (3m)1.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.95%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)3.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.29%
ROE 24.09%
ROCE 16.85%
ROIC 11.01%
ROICexc 11.01%
ROICexgc 16.57%
OM 12.48%
PM (TTM) 7.66%
GM 39.38%
FCFM 3.19%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)19.28%
ROE(5y)17.45%
ROIC(3y)10.65%
ROIC(5y)9.4%
ROICexc(3y)12.72%
ROICexc(5y)11.46%
ROICexgc(3y)22.87%
ROICexgc(5y)20.31%
ROCE(3y)16.29%
ROCE(5y)14.39%
ROICexcg growth 3Y10.2%
ROICexcg growth 5Y5.6%
ROICexc growth 3Y10.16%
ROICexc growth 5Y6.74%
OM growth 3Y-0.37%
OM growth 5Y-2.84%
PM growth 3Y1.12%
PM growth 5Y-5.87%
GM growth 3Y1.48%
GM growth 5Y-0.7%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 10.38
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.61%
Interest Coverage -6.92
Cash Conversion N/A
Profit Quality 41.6%
Current Ratio 1.32
Quick Ratio 0.82
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.81%
Cap/Sales(5y)7%
Profit Quality(3y)89.87%
Profit Quality(5y)105.14%
High Growth Momentum
Growth
EPS 1Y (TTM)16.41%
EPS 3Y16.59%
EPS 5Y5.3%
EPS Q2Q%51.15%
EPS Next Y13.57%
EPS Next 2Y9.71%
EPS Next 3Y9.29%
EPS Next 5YN/A
Revenue 1Y (TTM)23.14%
Revenue growth 3Y13.3%
Revenue growth 5Y12.63%
Sales Q2Q%9.81%
Revenue Next Year12.11%
Revenue Next 2Y8.04%
Revenue Next 3Y8.01%
Revenue Next 5YN/A
EBIT growth 1Y17.07%
EBIT growth 3Y12.89%
EBIT growth 5Y9.43%
EBIT Next Year49.57%
EBIT Next 3Y18.65%
EBIT Next 5YN/A
FCF growth 1Y-68.78%
FCF growth 3Y-31.39%
FCF growth 5Y-18.84%
OCF growth 1Y-3.21%
OCF growth 3Y4.55%
OCF growth 5Y6.17%